Heme oxygenase-1 (HO-1)/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-κB activation
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Heme oxygenase (HO-1) catalyzes heme to carbon monoxide (CO), biliverdin/bilirubin, and iron and is known to prevent the pathogenesis of several human diseases. We assessed the beneficial effect of heme degradation products on osteoclastogenesis induced by receptor activator of NF-κB ligand (RANKL). Treatment of RAW264.7 cells with CORM-2 (a CO donor) and bilirubin, but not with iron, decreased RANKL-induced osteoclastogenesis, with CORM-2 having a more potent anti-osteogenic effect. CORM-2 also inhibited RANKLinduced osteoclastogenesis and osteoclastic resorption activity in marrow-derived macrophages. Treatment with hemin, a HO-1 inducer, strongly inhibited RANKL-induced osteoclastogenesis in wild-type macrophages, but was ineffective in HO-1＋/- cells. CORM-2 reduced RANKL-induced NFATc1 expression by inhibiting IKK-dependent NF-κB activation and reactive oxygen species production. These results suggest that CO potently inhibits RANKL-induced osteoclastogenesis by inhibiting redox-sensitive NF-κB-mediated NFATc1 expression. Our findings indicate that HO-1/CO can act as an antiresorption agent and reduce bone loss by blocking osteoclast differentiation.
Abstract
Heme oxygenase (HO-1) catalyzes heme to carbon monoxide (CO), biliverdin/bilirubin, and iron and is known to prevent the pathogenesis of several human diseases. We assessed the beneficial effect of heme degradation products on osteoclastogenesis induced by receptor activator of NF-κB ligand (RANKL). Treatment of RAW264.7 cells with CORM-2 (a CO donor) and bilirubin, but not with iron, decreased RANKL-induced osteoclastogenesis, with CORM-2 having a more potent anti-osteogenic effect. CORM-2 also inhibited RANKLinduced osteoclastogenesis and osteoclastic resorption activity in marrow-derived macrophages. Treatment with hemin, a HO-1 inducer, strongly inhibited RANKL-induced osteoclastogenesis in wild-type macrophages, but was ineffective in HO-1＋/- cells. CORM-2 reduced RANKL-induced NFATc1 expression by inhibiting IKK-dependent NF-κB activation and reactive oxygen species production. These results suggest that CO potently inhibits RANKL-induced osteoclastogenesis by inhibiting redox-sensitive NF-κB-mediated NFATc1 expression. Our findings indicate that HO-1/CO can act as an antiresorption agent and reduce bone loss by blocking osteoclast differentiation.
참고문헌 (24)
- Asagiri M and Takayanagi H, "The molecular understanding of osteoclast differentiation", Bone, 40, pp.251~264 (2007)
- Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
- Kobayashi N, "Segregation of TRAF6-mediated signalling pathways clarifies its role in osteoclastogenesis", EMBO J, 20, pp.1271~1280 (2001)
- Walsh MC, "Osteoimmunology: interplay between the immune system and bone metabolism", Annu Rev Immunol, 24, pp.33~63 (2006)
- Asagiri M, "Autoamplification of NFATc1 expression determines its essential role in bone homeostasis", J Exp Med, 202, pp.1261~1269 (2005)
- Ayer A, "Heme oxygenases in cardiovascular health and disease", Physiol Rev, 96, pp.1449~1508 (2016)
- Kim YM, "Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities", Antioxid Redox Signal, 14, pp.137~167 (2011)
- Van Phan T, "Carbon monoxide protects against ovariectomy-induced bone loss by inhibiting osteoclastogenesis", Biochem Pharmacol, 85, pp.1145~1152 (2013)
- Tseng FJ, "Carbon monoxide inhibits receptor activator of NF-B (RANKL)- induced osteoclastogenesis", Cell Physiol Biochem, 36, pp.1250~1258 (2015)
- Ke K, "Hemeoxygenase-1 maintains bone mass via attenuating a redox imbalance in osteoclast", Mol Cell Endocrinol, 409, pp.11~20 (2015)
- Boyce BF, "Advances in the regulation of osteoclasts and osteoclast functions", J Dent Res, 92, pp.860~867 (2013)
- Ryter SW, "Heme oxygenase- 1", carbon monoxide: from basic science to therapeutic applications, 2006, pp.86, 583~650
- Lee S, "Carbon monoxide confers protection in sepsis by enhancing beclin 1-dependent autophagy and phagocytosis", Antioxid Redox Signal, 20, pp.432~442 (2014)
- Choi YK, "Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury", Nat Med, 22, pp.1335~1341 (2016)
- Takayanagi H, "Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell, 3, pp.889~901 (2002)
- Santoro MG, "NF-B and virus infection: who controls whom", EMBO J, 22, pp.2552~2560 (2003)
- Nakahira K, "Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts", J Exp Med, 203, pp.2377~2389 (2006)
- Chi PL, "HO-1 induction by CO-RM2 attenuates TNF-- induced cytosolic phospholipase A2 expression via inhibition of PKC-dependent NADPH oxidase", ROS and NF-B, 2014, pp.2014, 279171~
- Lee NK, "A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation", Blood, 106, pp.852~859 (2005)
- Ha H, "Reactive oxygen species mediate RANK signaling in osteoclasts", Exp Cell Res, 301, pp.119~127 (2004)
- Stocker R, "Bilirubin is an antioxidant of possible physiological importance", Science, 235, pp.1043~1046 (1987)
- Yeh PY, "CO-releasing molecules and increased heme oxygenase-1 induce protein S-glutathionylation to modulate NF-B activity in endothelial cells", Free Radic Biol Med, 70, pp.1~13 (2014)
- 강나나, "A systematic study of nuclear interactome of C-terminal domain small phosphatase-like 2 using inducible expression system and shotgun proteomics", BMB Reports, 49(6), pp.319~324 (2016), 생화학분자생물학회
- 박근수, "Anti-inflammatory action of ethanolic extract of Ramulus mori on the BLT2-linked cascade", BMB Reports, 49(4), pp.232~237 (2016), 생화학분자생물학회